Processa Pharmaceuticals, Inc. Debt Instrument, Convertible, Conversion Price
Processa Pharmaceuticals, Inc. (PCSA) had Debt Instrument, Convertible, Conversion Price of $14.28 per share as of 2020-03-31, per its 10-Q filed 2020-05-15.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleConversionPrice1 · last filed 2020-05-15
- 2020-03-31: Debt Instrument, Convertible, Conversion Price $14.28.
- 2019-12-31: Debt Instrument, Convertible, Conversion Price $14.28.
- 2018-05-25: Debt Instrument, Convertible, Conversion Price $2.04.
| Period end | Debt Instrument, Convertible, Conversion Price |
|---|---|
| 2020-03-31 | $14.28 10-Q · filed 2020-05-15 |
| 2019-12-31 | $14.28 10-K · filed 2020-03-06 |
| 2018-05-25 | $2.04 10-K/A · filed 2019-04-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |